{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:18:27Z","timestamp":1781191107976,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.exger.2019.110778","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:53:14Z","timestamp":1573041194000},"page":"110778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The multiple faces of tryptophan in bone biology"],"prefix":"10.1016","volume":"129","author":[{"given":"Ahmed","family":"Al Saedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulmira","family":"Nurgali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.exger.2019.110778_bb0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cei.12288","article-title":"Interferon (IFN)-gamma-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study","volume":"176","author":"Apalset","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.exger.2019.110778_bb0010","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00198-014-2720-7","article-title":"Interferon gamma (IFN-gamma)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study","volume":"25","author":"Apalset","year":"2014","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice","volume":"396","author":"Ball","year":"2007","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.exger.2019.110778_bb0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00198-018-4806-0","article-title":"Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study","volume":"30","author":"Bliuc","year":"2019","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"9","key":"10.1016\/j.exger.2019.110778_bb0025","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/jc.2010-0861","article-title":"Update in serotonin and bone","volume":"95","author":"Bliziotes","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0030","first-page":"151","article-title":"The serotonin and the bone assessment","volume":"6","author":"Carsote","year":"2013","journal-title":"Journal of medicine and life"},{"issue":"1\u20132","key":"10.1016\/j.exger.2019.110778_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(02)02284-9","article-title":"Control of serotonergic neurons in the dorsal raphe nucleus by the lateral hypothalamus","volume":"932","author":"Celada","year":"2002","journal-title":"Brain Res."},{"issue":"6349","key":"10.1016\/j.exger.2019.110778_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.exger.2019.110778_bb0045","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1073\/pnas.1117792109","article-title":"Decreased osteoclastogenesis in serotonin-deficient mice","volume":"109","author":"Chabbi-Achengli","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2019.110778_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"International journal of tryptophan research: IJTR"},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1096\/fj.07-9209com","article-title":"The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation","volume":"22","author":"Collet","year":"2008","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.exger.2019.110778_bb0060","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1590\/1414-431X20143565","article-title":"Serotonin regulates osteoblast proliferation and function in vitro","volume":"47","author":"Dai","year":"2014","journal-title":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas"},{"key":"10.1016\/j.exger.2019.110778_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"International journal of tryptophan research: IJTR"},{"issue":"4","key":"10.1016\/j.exger.2019.110778_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201006123","article-title":"The two faces of serotonin in bone biology","volume":"191","author":"Ducy","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exger.2019.110778_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-0135-0_32","article-title":"Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment","volume":"527","author":"Forrest","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.exger.2019.110778_bb0085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1440-1681.2006.04490.x","article-title":"Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment","volume":"33","author":"Forrest","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.exger.2019.110778_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198006","article-title":"Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: a prospective cohort study","volume":"13","author":"van Geel","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.exger.2019.110778_bb0095","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jbmr.462","article-title":"LRP5, serotonin, and bone: complexity, contradictions, and conundrums","volume":"26","author":"Goltzman","year":"2011","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.exger.2019.110778_bb0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0076-6879(99)08004-0","article-title":"Energy coupling through molecular discrimination: nicotinate phosphoribosyltransferase","volume":"308","author":"Grubmeyer","year":"1999","journal-title":"Methods Enzymol."},{"issue":"8","key":"10.1016\/j.exger.2019.110778_bb0105","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/js.2018-00118","article-title":"Osteoanabolic agents for osteoporosis","volume":"2","author":"Haas","year":"2018","journal-title":"Journal of the Endocrine Society"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2009.07.083","article-title":"Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?","volume":"46","author":"Haney","year":"2010","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biopsych.2012.11.003","article-title":"Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function","volume":"74","author":"Hodge","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.exger.2019.110778_bb0120","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/jbmr.439","article-title":"Efficacy of serotonin inhibition in mouse models of bone loss","volume":"26","author":"Inose","year":"2011","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.exger.2019.110778_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4137\/IJTR.S12626","article-title":"The kynurenine pathway in stem cell biology","volume":"6","author":"Jones","year":"2013","journal-title":"International journal of tryptophan research: IJTR"},{"issue":"5","key":"10.1016\/j.exger.2019.110778_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","article-title":"The burden of osteoporotic fractures: a method for setting intervention thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.11005\/jbm.2018.25.1.43","article-title":"The effect of antidepressants on mesenchymal stem cell differentiation","volume":"25","author":"Kruk","year":"2018","journal-title":"Journal of bone metabolism"},{"issue":"5","key":"10.1016\/j.exger.2019.110778_bb0140","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00726-010-0752-7","article-title":"Tryptophan metabolism, from nutrition to potential therapeutic applications","volume":"41","author":"Le Floc\u2019h","year":"2011","journal-title":"Amino Acids"},{"issue":"Suppl. 2","key":"10.1016\/j.exger.2019.110778_bb0145","first-page":"33","article-title":"Modulation of pancreatic enzyme secretion by melatonin and its precursor; L-tryptophan. Role of CCK and afferent nerves","volume":"55","author":"Leja-Szpak","year":"2004","journal-title":"Journal of physiology and pharmacology: an official journal of the Polish Physiological Society"},{"key":"10.1016\/j.exger.2019.110778_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.taap.2018.10.006","article-title":"Nicotinamide mononucleotide alleviates aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasome","volume":"362","author":"Liang","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0955-0674(03)00006-1","article-title":"Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease","volume":"15","author":"Lin","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1\u20133","key":"10.1016\/j.exger.2019.110778_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.04.060","article-title":"Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate","volume":"589","author":"Lin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.exger.2019.110778_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.exger.2019.110778_bb0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","article-title":"Structure and function of serotonin G protein-coupled receptors","volume":"150","author":"McCorvy","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.exger.2019.110778_bb0175","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","article-title":"Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan","volume":"67","author":"Metz","year":"2007","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.exger.2019.110778_bb0180","first-page":"779","article-title":"New insights into tryptophan and its metabolites in the regulation of bone metabolism","volume":"66","author":"Michalowska","year":"2015","journal-title":"Journal of physiology and pharmacology: an official journal of the Polish Physiological Society"},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1359\/jbmr.090721","article-title":"Relation of serum serotonin levels to bone density and structural parameters in women","volume":"25","author":"Modder","year":"2010","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"19","key":"10.1016\/j.exger.2019.110778_bb0190","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1111\/febs.12444","article-title":"The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells","volume":"280","author":"Moreno","year":"2013","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.exger.2019.110778_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1902\/jop.2015.150302","article-title":"Serotonin inhibits osteoblast differentiation and bone regeneration in rats","volume":"87","author":"Nam","year":"2016","journal-title":"J. Periodontol."},{"issue":"10","key":"10.1016\/j.exger.2019.110778_bb0200","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.4166","article-title":"Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect","volume":"22","author":"Ortuno","year":"2016","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.exger.2019.110778_bb0205","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/jbmr.3224","article-title":"Kynurenine, a tryptophan metabolite that accumulates with age, induces bone loss","volume":"32","author":"Refaey","year":"2017","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"12","key":"10.1016\/j.exger.2019.110778_bb0210","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00198-012-1935-8","article-title":"Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the global longitudinal study of osteoporosis in women (GLOW)","volume":"23","author":"Roux","year":"2012","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"21","key":"10.1016\/j.exger.2019.110778_bb0215","doi-asserted-by":"crossref","first-page":"15496","DOI":"10.1016\/S0021-9258(18)82284-0","article-title":"A mechanism for increased quinolinic acid formation following acute systemic immune stimulation","volume":"268","author":"Saito","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00223-013-9790-y","article-title":"Osteocytes: master orchestrators of bone","volume":"94","author":"Schaffler","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.exger.2019.110778_bb0225","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12020-013-9962-6","article-title":"Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats","volume":"44","author":"Sibilia","year":"2013","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00198-010-1274-6","article-title":"Oral bisphosphonate compliance and persistence: a matter of choice?","volume":"22","author":"Silverman","year":"2011","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"5","key":"10.1016\/j.exger.2019.110778_bb0235","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/ibd\/izy016","article-title":"The onset and progression of chronic colitis parallels increased mucosal serotonin release via enterochromaffin cell hyperplasia and downregulation of the serotonin reuptake transporter","volume":"24","author":"Stavely","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-0082(00)00032-0","article-title":"Kynurenines in the CNS: from endogenous obscurity to therapeutic importance","volume":"64","author":"Stone","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.exger.2019.110778_bb0250","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bone.2010.06.006","article-title":"Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures","volume":"47","author":"Verdel","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.exger.2019.110778_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bonekey.2012.120","article-title":"Serotonin: good or bad for bone","volume":"1","author":"de Vernejoul","year":"2012","journal-title":"BoneKEy reports"},{"issue":"1","key":"10.1016\/j.exger.2019.110778_bb0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/stem.1836","article-title":"The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis","volume":"33","author":"Vidal","year":"2015","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"7","key":"10.1016\/j.exger.2019.110778_bb0265","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1210\/jc.2012-4174","article-title":"Circulating serotonin and bone density, structure, and turnover in carcinoid syndrome","volume":"98","author":"Walsh","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"31","key":"10.1016\/j.exger.2019.110778_bb0270","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.exger.2019.110778_bb0275","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","article-title":"Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression","volume":"23","author":"Williams","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.exger.2019.110778_bb0280","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.exger.2019.110778_bb0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.exger.2019.110778_bb0290","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1096\/fj.201800883RRR","article-title":"Cumambrin a prevents OVX-induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways","volume":"33","author":"Zhou","year":"2019","journal-title":"FASEB J."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556519306126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556519306126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T02:44:05Z","timestamp":1759977845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556519306126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":58,"alternative-id":["S0531556519306126"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2019.110778","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multiple faces of tryptophan in bone biology","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2019.110778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110778"}}